Sapio completed the acquisition of a majority stake in Homeperf from Parquest Capital.

Sapio, a company in homecare and in the manufacture of industrial technical and medical gases, completed the acquisition of a majority stake in Homeperf, a homecare service provider specialized in perfusion, nutrition, insulin therapy and respiratory assistance, from Parquest Capital. Financial terms were not disclosed. "This acquisition marks an extremely important step, because France is the leading European market in homecare, a market whose worth is witnessing constant growth. It was therefore crucial for our growth strategy to strengthen our presence there, and Homeperf represented a unique development opportunity. I would like to thank the pool of funds that made this operation possible. Our aim now is to become one of the leading national players, with a strong brand, highly qualified staff, a widespread presence in the area and a great reputation," Mario Paterlini, Sapio Group CEO.